During the past decade, Ideta Eye Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ideta Eye Hospital" are "Diabetic Macular Edema" (2 trials), "Diabetic Mellitus" (1 trials), "Macular Degeneration" (1 trials), "Macular Edema" (1 trials) and "Neovascular Age-related Macular Degeneration" (1 trials). Many other conditions were trialed in "Ideta Eye Hospital" in a lesser frequency.

Most popular intervention types in "Ideta Eye Hospital" are "Drug" (6 trials), "Other" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (5 trials), "Faricimab" (4 trials), "Aflibercept" (2 trials), "Abicipar Pegol" (1 trials) and "Ranibizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ideta Eye Hospital" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Ideta Eye Hospital". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Ideta Eye Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ideta Eye Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".